monarchE: 13Y-MC-JPCF/NSABP B-58 A Randomized, Open-Label, Phase 3 Study of Abemaciclib Combined with Standard Adjuvant Endocrine Therapy versus Standard Adjuvant Endocrine Therapy Alone in Patients with High Risk Node Positive, Early Stage, Hormone Receptor Positive, Human Epidermal Receptor 2 Negative Breast Cancer

For more information on this trial, click the link below.

https://clinicaltrials.gov/ct2/show/NCT03155997?term=b-58&rank=1

Clinical Trial Categories

• Breast Cancer

Contact

Carolann Twelves, RN at 215-481-4149